Chicago, IL 的 小細胞肺癌 臨床試驗
13 項針對 小細胞肺癌 的研究正在 Chicago（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
招募中1 期
- The University of Chicago, Chicago
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
招募中3 期
- University of Chicago Medical Center /ID# 280149, Chicago
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- Northwestern University Feinberg School of Medicine, Chicago
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
招募中1/2 期
- University of Chicago ( Site 1108), Chicago
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
招募中2 期
- Northwestern, Chicago
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
招募中3 期
- Rush MD Anderson Cancer Center, Chicago
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
招募中1 期
- University of Illinois Chicago, Chicago
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
招募中2 期
- University of Illinois Chicago, Chicago
A Study of LY4175408 in Participants With Advanced Cancer
招募中1 期
- The University of Chicago Medical Center (UCMC), Chicago
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
招募中2 期
- University of Illinois Cancer Center, Chicago
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
招募中2 期
- Northwestern University, Chicago
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
招募中1/2 期
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
招募中2 期
- University of Chicago Medicine, Chicago
其他城市的 小細胞肺癌 試驗
- Houston, TX26 項研究
- Arlington, VA23 項研究
- New York City, NY22 項研究
- Boston, MA21 項研究
- Nashville, TN20 項研究
- Los Angeles, CA20 項研究
- Orlando, FL15 項研究
- Dallas, TX13 項研究
- Cleveland, OH13 項研究
- St. Louis, MO13 項研究
- Detroit, MI12 項研究
- Washington, DC12 項研究
Chicago 的其他研究
- 非小細胞肺癌61 項研究
- 乳癌59 項研究
- 癌症（所有類型）51 項研究
- 轉移性癌症45 項研究
- 前列腺癌45 項研究
- 肺癌41 項研究
- 肥胖症41 項研究
- 卵巢癌36 項研究
- 大腸直腸癌34 項研究
- 中風34 項研究
- 心臟衰竭31 項研究
- 過重29 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。